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Abstract
Purpose: To develop and characterize a mouse model with intraocular pressure (IOP) elevation after laser photocoagulation
on the trabecular meshwork (TM), which may serve as a model to investigate the potential of stem cell-based therapies for
glaucoma.
Methods: IOP was measured in 281 adult C57BL/6 mice to determine normal IOP range. IOP elevation was induced
unilaterally in 50 adult mice, by targeting the TM through the limbus with a 532-nm diode laser. IOP was measured up to 24
weeks post-treatment. The optic nerve damage was detected by electroretinography and assessed by semiautomatic
counting of optic nerve axons. Effects of laser treatment on the TM were evaluated by histology, immunofluorescence
staining, optical coherence tomography (OCT) and transmission electron microscopy (TEM).
Results: The average IOP of C57BL/6 mice was 14.562.6 mmHg (Mean 6SD). After laser treatment, IOP averaged above
20 mmHg throughout the follow-up period of 24 weeks. At 24 weeks, 57% of treated eyes had elevated IOP with the mean
IOP of 22.562.5 mmHg (Mean 6SED). The difference of average axon count (59.0%) between laser treated and untreated
eyes was statistically significant. Photopic negative response (PhNR) by electroretinography was significantly decreased.
CD45+ inflammatory cells invaded the TM within 1 week. The expression of SPARC was increased in the TM from 1 to 12
weeks. Histology showed the anterior chamber angle open after laser treatment. OCT indicated that most of the eyes with
laser treatment had no synechia in the anterior chamber angles. TEM demonstrated disorganized and compacted
extracellular matrix in the TM.
Conclusions: An experimental murine ocular hypertension model with an open angle and optic nerve axon loss was
produced with laser photocoagulation, which could be used to investigate stem cell-based therapies for restoration of the
outflow pathway integrity for ocular hypertension or glaucoma.
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Introduction
Glaucoma is a major cause of blindness throughout the world
and the second leading cause of irreversible blindness in the USA
[1,2]. Primary open angle glaucoma (POAG), the most common
form of glaucoma, is characterized by a progressive optic
neuropathy with loss of retinal ganglion cells (RGC) and optic
nerve axons, resulting in impairment of visual function. An
elevated intraocular pressure (IOP) is the most important risk
factor for most forms of glaucoma including POAG. Experimental
animal glaucoma models are normally generated by increasing
IOP which reproduces many pathophysiological changes observed
in human glaucoma patients [3].
The IOP is regulated primarily by a fluid resistance to the
aqueous humor outflow [4]. The juxtacanalicular connective tissue
(JCT) and Schlemm’s canal endothelial cells are generally believed
to be the major sites of resistance to the aqueous outflow, and
hence the primary determinants of IOP [5–7]. Trabecular
meshwork (TM) cells are also believed to have a major role in
regulation of the aqueous outflow. For example, TM cells
modulate the permeability of Schlemm’s canal endothelial cells
in vitro via paracrine signaling [8–11], and keep the aqueous
outflow channels patent via phagocytic activities [12,13]. Further,
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a decrease in TM cellularity was observed both in aged and
glaucomatous eyes [14–22]. The presence of outflow tract
pathologies and role of IOP elevation in glaucoma justify the use
of ocular hypertensive animal models for the study of RGC
damage without ancillary injury to the retina and ocular structures
[23]. Laser photocoagulation of the distal outflow pathway is
frequently used to elevate IOP in animal models. Levkovitch-
Verbin et al [24] reported the translimbal laser photocoagulation
approach to create a rat glaucoma model. Since then, many
groups have induced ocular hypertension in animal models by
using laser photocoagulation of the anterior angle and episcleral
veins [3,25–36]. Aihara et at [25] showed that laser on mouse eyes
with pupil dilation and anterior chamber flattening induced
significant IOP increase with completely closed angle. Fu and
Sretavan [29] applied laser on limbal and episcleral veins of albino
mice and the IOP was doubled within 4 hrs but returned to
normal by 7 days. They claimed [30] that, in C57BL/6 mice, no
consistent and reproducible results with laser-induced ocular
hypertension were obtained.
Using stem cells to repopulate the TM in glaucomatous eyes is
one of the potential therapy strategies for POAG. We have already
successfully isolated and characterized stem cells from human TM
[37] and proved that these stem cells have the ability to home to
the TM region after being transplanted into normal mouse
Figure 1. IOP range of normal C57BL/6 mouse population. IOP was measured on 281 healthy adult C57BL/6 mice under anesthesia. IOP of
right (OD) and left eyes (OS) were recorded and analyzed separately. X-axis represents the IOP and y-axis represents the frequency distribution at
different IOP levels.
doi:10.1371/journal.pone.0107446.g001
Table 1. IOP distribution of normal C57BL/6 mice.
IOP (mmHg) Mean SD 95th percentile 97.5th percentile 99.5th percentile
OD 14.6 2.6 19 20 20.4
OS 14.4 2.7 19 20 20.2
OU 14.5 2.6 19 20 20.3
doi:10.1371/journal.pone.0107446.t001
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anterior chamber [38]. In the present study, we developed a
mouse model with IOP elevation by damaging the TM with laser
photocoagulation. We characterized the effects of the TM damage
to determine the model’s suitability to investigate the potential of
stem cell-based therapies for the outflow pathway reconstruction
for glaucoma.
Materials and Methods
Materials
Antibodies used include anti-CD-45-PE conjugated (BD
Pharmingen, San Diego, CA) and SPARC (R&D Systems,
Minneapolis, MN). Goat anti-mouse IgG Alexa-488 secondary
antibody, Alexa Fluor 633 phalloidin and 49, 6-diamidino-2-
phenylindole (DAPI) were purchased from Life Technologies
(Carlsbad, CA). TUNEL assay kit (In Situ Cell Death Detection
Kit, TMR red) was from Roche Molecular Biochemicals
(Indianapolis, IN).
Animals
Healthy adult female and male C57BL/6 mice aged from 4-
week to 2-year old were purchased from Charles River Labora-
tories International, Inc. (Wilmington, MA). Mice were main-
tained in the University of Pittsburgh Animal Facility with low-
light conditions and a 12-hour light-dark cycle and free access to
food and water. All experimental procedures were reviewed and
approved by the University of Pittsburgh Institutional Animal
Care and Use Committee and handled according to guidelines
provided in the Association for Research in Vision and Ophthal-
mology Resolution on the Use of Animals in Ophthalmic and
Vision Research.
IOP was measured under the housing low-light conditions in
the afternoons at approximately the same time using a rebound
tonometer for rodents (TonoLab; Colonial Medical Supply,
Franconia, NH) on mice that had been anesthetized by
intraperitoneal injection of 2 mg of ketamine hydrochloride and
0.2 mg of xylazine (IVX Animal Health, Inc., St. Joseph, MO)
mixed in 0.2 ml of Dulbecco’s phosphate buffered saline (PBS).
Baseline IOP was measured prior to the laser treatment.
Figure 2. IOP elevation after laser treatment. IOP of laser treated and fellow untreated eyes was shown at different time points after laser.
Values are mean6SEM. Dashed line represents the 99.5th percentile of normal IOP range as shown in Table 1. The difference between two groups at
each time points is statistically significant (p,0.05, paired t-test).
doi:10.1371/journal.pone.0107446.g002
Table 2. IOP changes at different time points after laser treatment.
Time Points Eyes (n) IOP(Mean ±SEM) (mmHg)
Laser treated Untreated Controls
Baseline 50 13.760.7 14.160.5
1 day 50 22.961.2 14.860.7
1 wk 43 22.562.6 12.860.5
2 wks 36 21.363.8 14.360.5
12 wks 29 21.062.9 15.061.1
24 wks 22 22.562.5 13.460.5
doi:10.1371/journal.pone.0107446.t002
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Laser photocoagulation was performed on 8–12 weeks old
C57BL/6 female mice using a 532 nm cw-diode laser (OcuLight
GL Diode Laser, IRIDEX) at 80-mW laser power, 150-ms
duration and 50-mm diameter spot size determined after prelim-
inary studies with different combinations of the parameters for
laser treatment. Approximately 25 laser burns were delivered at
the gray zone of the limbus of each mouse. A second laser
treatment was performed one week after. IOP was measured two
to three times a week for the first 3 weeks after laser and once a
week thereafter.
In this study, 50 eyes were treated with laser and mice were
sacrificed at 1 day, 1 week, 2 weeks and 12 weeks after the second
laser treatment for histology and transmission electron microscopy
(TEM). Three pairs of optic nerves with and without laser
treatment were collected for toluidine blue staining to quantify the
optic nerve axon damage.
Electroretinography (ERG) was performed on both treated
and untreated eyes at 20 weeks following laser treatment using an
Espion Diagnosys system (Diagnosys LLC, Littleton, MA). After
overnight dark adaptation (minimum 12 hours), mice were
prepared for ERG recording under dim red illumination. Pupil
dilation and topical anesthesia were achieved by topical applica-
tion of 1 drop each of 0.5% tropicamide (Akorn, Lake Forest, IL)
and 0.5% proparacaine hydrochloride (Falcon Pharmaceuticals,
Fort Worth, TX). Body temperature was maintained at 37uC with
a homeothermic controller and unit. Electrical signals were
recorded with two 3-mm gold wire loop electrodes (Diagnosys)
contacting the corneal surface of eyes precoated with a 2.5%
hydroxypropyl-methylcellulose solution (Gonak, Akorn). A sub-
dermal needle electrode (Viasys Healthcare, Chicago, IL) between
the ears served as common reference while the other subdermal
needle electrode inserted at the base of the left leg acted as ground.
Retinal responses were recorded simultaneously from both eyes.
Light stimuli were delivered via a ColorDome unit. Three
different stimulus strengths of 1, 5 and 7 cd.s/m2 were used in a
3-step examination. In each step, the stimulus frequency was 2 Hz
with 4 ms of on time green light on a blue background with the
intensity of 10 cd/m2. At each intensity, 50 sweeps were recorded
with sample frequency at 1 kHz, sweep pre-trigger time of 10 ms
and sweep post-trigger time of 150 ms.
Data were analyzed using Espion software (Diagnosys LLC).
Amplitudes of the a-wave, b-wave and photopic negative response
(PhNR) were measured by identifying the maximum peak and
trough and obtaining the baseline trough and peak amplitude, and
then by taking the amplitude at a fixed criterion time after the
stimulus onset, again with respect to baseline.
In vivo imaging of mouse anterior segments was performed
using a high-resolution stereo fluorescence biomicroscope with
vertical fluorescence illuminator (Leica MZFLIII; Leica Micro-
systems Inc., Bannockburn, IL). Mice were anesthetized and
Figure 3. Mouse anterior chamber angle after laser treatment. A: Mouse eye at 4 weeks after laser treatment showing laser burn locations. B:
Plastic section of a normal control eye with anterior chamber angle open (arrowhead). C: Plastic section of a laser-treated eye at 4 weeks with anterior
chamber angle open (arrowhead). D–F: Representative images of SD-OCT scans. D: Normal control (IOP= 14 mmHg). E: Laser treated eye at 20 weeks
(IOP = 30 mmHg) with anterior chamber angle open. F: Laser treated eye at 20 weeks with partial synechia (pointed by arrows, IOP= 28 mmHg). SD-
OCT scans of each eye show the angles with rotations of the eye at 0, 45, 90 and 135 degrees. AC, anterior chamber. TM, trabecular meshwork. SC,
Schlemm’s canal. IOP, intraocular pressure.
doi:10.1371/journal.pone.0107446.g003
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immobilized with a three-point stereotactic mouse restrainer as
previously described [39,40]. Images were obtained at a magni-
fication of 256with visibility to the limbus, anterior chamber, iris,
pupil, and lens.
Spectral-domain optical coherence tomography (SD-
OCT) scanning was adapted from the procedures described
previously [41,42]. Before each session, mice were anesthetized
with an intraperitoneal injection of ketamine and xylazine to
prevent large movements during SD-OCT image acquisition.
Mice were secured on a custom stage that allowed for free rotation
to acquire images focusing on the cornea. Images centered on the
cornea were acquired using SD-OCT (Bioptigen, Inc., Research
Triangle Park, NC). All SD-OCT images consisted of a 2506250
A-scan array; there were 250 A-scans per B-scan, 250 B-scan
frames, and 1024 samplings/A-scan in depth.
Histology
For plastic sectioning, enucleated mouse eyeballs were fixed in
2% glutaraldehyde in 0.1 M PBS at room temperature for 2 hours
followed by post-fixation in 10% formalin at room temperature
overnight. Samples were embedded in plastic (JB-4, Electron
Microscopy Sciences, Hatfield, PA), sectioned for 2- mm thickness
and stained with hematoxylin and eosin.
All other procedures were carried out as described previously
[40]. In brief, enucleated mouse eyeballs were fixed in 1%
paraformaldehyde at 4uC overnight followed by either storage at
4uC in 50% glycerol and 50% PBS (v/v) for wholemount staining
or frozen at 220uC in optimal cutting temperature embedding
compound (Tissue-Tek OCT; Electron Microscopy Sciences,
Hatfield, PA) and cut into 9-mm thick cryosections on a cryostat
for immunofluorescence. Sections were hydrated in PBS and
postfixed in 2% paraformaldehyde for 15 minutes. Nonspecific
binding was blocked with 10% heat-inactivated goat serum and
anti-mouse CD16/CD32 Fcc III/II (BD Pharmingen). Sections
were incubated with primary antibodies overnight at 4uC. After
two rinses in PBS, secondary antibodies and DAPI were added for
1 hour at room temperature. Images were acquired on a confocal
microscope with a 406 objective (Olympus FluoView FV1000
confocal microscope; Olympus, Center Valley, PA).
Wholemount Stain. After fixation, eyes were cut 1.5 mm
posterior to the limbus. The anterior part, including the cornea
and TM, was cut into quarters for wholemount stain. The iris was
carefully removed before staining. Nonspecific binding was
blocked as described above. The tissue was incubated with anti-
CD45 antibody conjugated PE and phalloidin-633 (stains F-actin)
overnight at 4uC. Following five washes, the tissue was incubated
with DAPI for 10 min at room temperature prior to confocal
imaging. Stitched image stacks were acquired by sequential
scanning to avoid fluorescence crossover on a confocal microscope
(Olympus).
TUNEL assay was performed using a cell death detection kit (In
Situ Cell Death Detection Kit) following the manufacturer’s
protocol on cryopreserved tissue. Nuclei were stained with DAPI.
At least three independent TM tissues from each condition and
eight sections of each condition were stained and imaged using a
confocal microscope.
Transmission Electron Microscopy (TEM)
The ultrastructure of mouse TM was examined by TEM.
Mouse eyeballs were fixed in cold 2.5% glutaraldehyde (EM
Figure 4. Photopic negative response (PhNR) of normal and laser-treated mouse eyes. A: a wave, b wave and PhNR of untreated left
control eye (OS) and laser-treated right eye (OD) of step 1 with the stimulus at 1 cd.s/m2. B: Depicts the waves of step 2 with the stimulus at 5 cd.s/
m2. C: Represents the waves of step 3 with the stimulus at 7 cd.s/m2. D: Shows the statistical analysis of the amplitude of PhNR at step 2 with the
stimulus at 5 cd.s/m2 compared to the laser-treated and untreated control eyes (p,0.0001, paired t-test).
doi:10.1371/journal.pone.0107446.g004
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grade, Taab Chemical) in 0.1 M PBS pH 7.3, rinsed in PBS, and
were then post-fixed in 1% osmium tetroxide (Electron Micros-
copy Sciences) with 1% potassium ferricyanide (Fisher). They were
dehydrated through a graded series of ethanol baths and
embedded in Epon (made from dodecenyl succinic anhydride,
nadic methyl anhydride, Scipoxy 812 Resin and 2,4,6-tris(di-
methylaminomethyl)phenol, Energy Beam Sciences). Semi-thin
(300 nm) sections were cut on a Reichart Ultracut, stained with
0.5% toluidine blue (Fisher) and examined under a light
microscope. Ultrathin sections (65 nm) stained with uranyl acetate
(Electron Microscopy Sciences) and Reynold’s lead citrate (Fisher)
were examined and photographed at 80 kV on a Jeol 1011
transmission electron microscope.
Mouse Optic Nerve Axon Assessment
Optic nerves were dissected from 1 mm behind the eyes to the
optic chiasm. Fixation followed the same procedures that were
used for TEM. The proximal part of the optic nerve was cross-
sectioned at 0.5 mm and stained with 1% toluidine blue. Images
were acquired using light microscopy with a BX60 microscope
(Olympus) equipped with a Spot digital camera (Diagnostics
Instruments, Inc., Sterling Heights, CA). For each nerve, at least
five 606 fields were acquired. Axon number counts and average
axon number per mm2 were analyzed by a masked observer using
ImageJ software (National Institute of Health, Bethesda, MD).
Statistical Analysis
All values are presented as mean 6SD or mean 6SEM. The
statistical differences were determined by paired t-test to assess the
significance of differences between two groups. Statistical signif-
icance was set at p,0.05. For IOP distribution on normal eyes,
D’Agostino-Pearson normality test was performed.
Results
IOP of Normal C57BL/6 Mice Are Normally Distributed
The IOP of 281 healthy adult C57BL/6 mice of both sexes aged
from 4-week to 2-year old was measured. The average IOP was
14.662.5 mmHg (mean 6SD, n= 281) in right eyes (OD) and
14.462.7 mmHg (mean 6SD, n= 281) in left eyes (OS) (Table 1).
There was no statistically significant difference between two eyes
(p=0.2648, paired t-test). The IOP of both eyes are normally
distributed (Fig 1) (p=0.4735, D’Agostino-Pearson normality test)
Figure 5. RGC and optic nerve axonal damage following IOP elevation. A and B represent images of plastic-embedded retinal sagittal
sections peripheral to the optic nerve with hemotoxylin-eosin staining. A: Laser-treated. B: Normal control. C: Statistical analysis of the RGC number
counts (p,0.001, paired t-test). D and E show toluidine blue staining of semithin transverse sections of optic nerves. D: Laser treated eye with swollen
axons (arrowheads) and shrunken axons (arrows). E: Normal control with more homogeneous axons. D1–E1 are magnified views of the regions
encased in black boxes in D–E. F Represents the statistical analysis of the axons (p,0.0001, paired t-test). RNFL, retinal nerve fiber layer; RGC, retinal
ganglion cells; IPL, inner plexiform layer; INL, inner nuclear layer; OPL, outer plexiform layer; ONL, outer nuclear layer.
doi:10.1371/journal.pone.0107446.g005
Laser Induced Mouse Glaucoma Model
PLOS ONE | www.plosone.org 6 September 2014 | Volume 9 | Issue 9 | e107446
with 20 mmHg as the top 97.5th percentile and 20.3 mmHg as
the top 99.5th percentile of normal IOP range in C57BL/6 mice.
Laser Photocoagulation to the TM Induces IOP Elevation
The IOP changes between laser-treated and untreated control
eyes at different post-treatment time points are shown in Table 2
and Fig 2. The average IOP of laser treated eyes were above
20.3 mmHg, which is the top 99.5th percentile of normal IOP of
C57BL/6 mice. In contrast, the average IOP of untreated eyes
were below 20.3 mmHg. The IOP difference between treated and
untreated eyes at each time point post-laser treatment was
statistically significant (p,0.05, paired t-test).
The laser burns at the limbus were still visible at 4 weeks after
laser treatment (Fig 3A), which indicates where the laser beams
were shot through. Plastic sections show the anterior chamber
angle of laser-treated eye remained open at 4 weeks after laser
(Fig 3C), similar to that of normal control (Fig 3B).
SD-OCT scanning was used to detect the anterior chamber
angle. The open-angle of normal eyes throughout 360 arc was
shown as Figs 3D-0, D-45, D-90, D-135. Sixteen out of 18 laser-
treated eyes that received OCT examination had open anterior
chamber angles (Fig 3E-0, E-45, E-90, E-135) and only 2 eyes
(11%) had partial synechia (,180u, Figs 3F-0, F-45, F-90, F-135).
Since the laser beams were controlled to be outside of the
anterior chamber angle, hyphema was only observed in one eye
Figure 6. SPARC immunolocalization in the TM. A1–E1: DAPI stains nuclei as blue in the cryosections. A2–E2: SPARC stains the TM and
peripheral cornea and sclera green. A3–E3: Bright field images for tissue orientation. A–E: Merged fluorescent images and bright field provide detailed
structural orientation. Asterisk (*) shows the location of Schlemm’s canal (SC). Arrow points the TM. Anterior chamber (AC) and iris are indicated as
well. A: Untreated control. B: 24 hrs after laser treatment. C: 1 week after laser. D: 2 weeks after laser. E: 12 weeks after laser. Bars, 50 mm.
doi:10.1371/journal.pone.0107446.g006
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out of 50 (2%) laser-treated eyes and no other side effects or
complications were observed as a result of this treatment.
IOP Elevation by Laser Photocoagulation Results in Optic
Nerve Damage
RGC function was evaluated using ERG. Fifty sweeps were
recorded at 3 different stimulus strengths at 1 (step 1), 5 (step 2),
and 7 cd.s/m2 (step 3) and the patterns of the PhNR changes at all
three stimuli were about the same. Fig 4A, 4B and 4C are
representative ERG waves under 3 different stimuli and the
amplitude of PhNR of laser treated eye decreased comparing to
the untreated contralateral eye, whereas the amplitudes of a-wave
and b-wave did not show much difference between laser-treated
and untreated eyes. Under stimulus of 5 cd.s/m2, the average
amplitude of PhNR of the untreated control eyes was 2
41.2962.70 mV (mean 6SEM) and that of laser treated eyes at
20 weeks was 219.5062.51 mV (mean 6SEM). The difference
was statistically significant (p,0.0001, paired t-test, Fig 4D).
The characteristic of glaucomatous damage is the RGC loss
while other retinal layers are relatively spared. Retinal histology at
24 weeks after laser treatment demonstrated prominent RGC cell
loss and diminution of the retinal nerve fiber layer (RNFL)
(Fig 5A) compared to normal controls (Fig 5B). The reduction of
RGC number in laser-treated eyes compared to normal controls
was statistically significant (p,0.001, paired t-test, Fig 5C).
Toluidine blue staining on 0.5 mm optic nerve sections showed
swollen (arrowheads) and shrunken (arrows) axons in the optic
nerve of laser treated with IOP-elevated eyes (Fig 5D, D1) relative
to the fellow untreated normal eyes (Fig 5E, E1). The axon
numbers were counted semiautomatically using ImageJ and the
axon numbers per mm2 were calculated. At least five 606fields per
nerve were counted. The average axon number per mm2 was
reduced by 59.0% at 24 weeks in laser treated eyes compared to
untreated eyes (Fig 5F) (0.0760.01 axons/mm2 of eyes with laser
treatment vs 0.1860.02 (Mean 6SD) of untreated eyes, p,
0.0001).
Figure 7. CD45 and F-actin immunolocalization in the TM wholemounts. A1–E1: DAPI stains nuclei as blue in the wholemounts. A2–E2:
Inflammatory cells positive to CD45 (red) appear at 24 hrs after laser (B2) and decrease thereafter. A3–E3: F-actin (Green) stains the TM cells clearly
shown the location of the TM region. A–E: Merged fluorescent images provide detailed structural orientation. The TM and cornea are indicated. A:
Untreated control. B: 24 hrs after laser treatment. C: 1 week after laser. D: 2 weeks after laser. E: 12 weeks after laser. Bars, 50 mm.
doi:10.1371/journal.pone.0107446.g007
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Laser Induces Inflammatory Response and Fibrosis on the
Outflow Pathway
Fig 6 shows SPARC staining on cryosections of normal control
and eyes of 24 hrs, 1 week, 2 weeks, 12 weeks after laser treatment.
SPARC expression was increased in the TM region as well as in
the peripheral cornea and sclera at 1 week after laser treatment
(Fig 6C) and it was remained in the TM region up to 12 weeks
(Fig 6E). Laser treatment causes an obvious inflammatory
response with anterior chamber infiltration in some eyes. Fig 6B
shows SPARC staining in the anterior chamber indicating
inflammatory infiltration at 24 hrs after laser. Wholemount
staining (Fig 7) demonstrated that the expression of inflammatory
cell marker CD45 peaked at 24 hrs (Fig 7B) after laser treatment
in the TM region and was decreased at 1 week (Fig 7C) and
continued to decline thereafter. There was almost no CD45
expression in the TM region at 12 weeks after laser (Fig 7E),
similar to the normal control (Fig 7A). F-actin staining showed the
localization of the TM (Fig 7A3–E3).
TM Microstructure Changes are Related to IOP Elevation
The ultrastructure of mouse TM was examined by TEM.
Fig 8A shows normal mouse TM containing trabecular beams
with aligned collagen fibrils and three layers of normal TM cells.
Giant vacuoles among the Schlemm’s canal endothelial cells could
be seen. The JCT appeared loose and disorganized compared to
the organized trabecular beams in the TM. Twenty-four hrs after
laser, there were only 1–2 layers of TM cells with some apoptotic
without organelles (Fig 8B1, arrows). The beams were disorga-
nized. Twelve weeks after laser, the TM tissue had more
compacted JCT and collagen fibrils and disorganized ECM
(Fig 8C, C1) compared to the normal structure (Fig 8A, A1). No
giant vacuoles could be seen in the Schlemm’s canal endothelial
cells 12 weeks after laser (Fig 8C).
Laser Photocoagulation Caused TM Cell Apoptosis
Apoptotic cells were detected in the corneal epithelium but not
in the TM region in the normal control (Fig 9A) by TUNEL
staining. There were many apoptotic cells in the TM region as well
as the other tissues in the limbal region 24 hrs after laser treatment
(Fig 9B). At 1 week, 2 weeks and 12 weeks after laser, less
apoptotic cells were detected in the TM region (Figs 9C, D, E).
Discussion
In the present study, we developed and characterized a mouse
model using laser photocoagulation on the TM tissue through the
limbus. IOP elevation lasted up to 24 weeks while maintaining an
open anterior chamber angle and induced RGC damage
demonstrated by PhNR changes and optic nerve axon loss. Laser
photocoagulation elicited an acute inflammatory response and
apoptosis in the TM region and induced fibrotic response and
extracellular matrix (ECM) disorganization in the outflow pathway
at later times. The IOP elevation presumably was induced by the
structural changes other than mechanical blockage by anterior
chamber angle synechia. This model may be suitable for stem cell-
based therapies for remodeling and reconstructing the outflow
pathway to maintain regular IOP and prevent optic nerve
damage.
We measured the IOP of 281 healthy adult C57BL/6 mice and
provided reliable documentation of normal IOP range and IOP
distribution in C57BL/6 mice. 97.5th and 99.5th percentiles of the
IOP of normal mice were determined. Clinically 99.5th percentile
of the normal population has been used as the diagnostic threshold
of pathogenic IOP when it is impossible to check the visual fundus
and visual function [43]. The average IOP of laser treated eyes in
this study at each time point after laser was above the 99.5th
percentile. It has been reported that ketamine administration
could affect mouse IOP and accurate IOP measurement in mice
must be made within minutes [44]. By measuring IOP of normal
mice immediately after anesthesia, we acquired a normally
Figure 8. TM ultrastructure changes after laser. The region encased in the black box in the upper row is magnified in the lower row. A and A1:
TEM of normal mouse TM revealed aligned collagen beams with three layers of normal TM cells. A giant vacuole (V) was seen. The JCT appeared loose
and disorganized. B and B1: 24 hrs after laser, the TM tissue had only 1–2 layers of cells with disorganized beams. C and C1: 12 weeks after laser, the
TM had disorganized beams and the collagen fibrils were more compacted compared to the normal structure and the JCT was more compacted with
more and disorganized extracellular matrix. Abbreviations: SC, Schlemm’s canal; JCT, Juctacanalicular connective tissue; V, giant vacuole.
doi:10.1371/journal.pone.0107446.g008
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distributed IOP of normal mice and we concluded that the method
we used to measure mouse IOP is reliable.
Many studies [3,25–30] have worked on mice and rats to make
glaucoma models using laser photocoagulation. They all focused
on increasing IOP and inducing optic nerve damage but did not
attempt to keep the normal morphology of the anterior segment
and did not clarify the pathological changes of the outflow
pathway and TM tissue. In this study, we treated the eyes
specifically in several aspects. First, instead of dilating the pupils to
cause mydriasis prior to laser treatment, we used 1% pilocarpine
for miosis to open the angle. Grozdanic et al [28] also used
pilocarpine in their study to increase outflow of photosensitive dye
to the TM. Second, we did not drain the aqueous humor to flatten
the anterior chamber. Third, we did not burn and block the
episcleral veins. With less energy and smaller laser spot size, we
successfully avoided the angle synechia which disturbs the TM
structure and renders the model unsuitable for cell-based therapies
for TM remodeling. Grozdanic et al [28] and Gunn et al [45] used
similar parameters with 810 nm diode laser to build their high
IOP animal models, but they either did not check the anterior
chamber angle or found closed anterior chamber angle. Our data
show that laser damage to the outflow pathway, even without
mechanical blockage at the angle, can induce structural and hence
functional changes to the outflow pathway to effectively elevate
IOP for up to 24 weeks.
Figure 9. TUNEL staining on cryosections. A1–E1: DAPI stains nuclei as blue. A2–E2: TUNEL assay stains apoptotic cells as red peak at 24 hrs after
laser (B2). A3–E3: Bright field for tissue orientation. A–E: Merged fluorescent images and bright field provide detailed structural orientation. Asterisk (*)
represents the location of Schlemm’s canal (SC). Arrow points the TM. Anterior chamber (AC) and iris are indicated as well. A: Untreated control. B:
24 hrs after laser treatment. C: 1 week after laser. D: 2 weeks after laser. E: 12 weeks after laser. Bars, 50 mm.
doi:10.1371/journal.pone.0107446.g009
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To confirm that the IOP elevation was caused by the outflow
structural changes but not mechanical synechia, we used SD-OCT
as well as histology to detect the anterior chamber angle. We show
that among eighteen eyes with laser treatment, only two eyes had
synechia of less than 180 arc and all the others had completely
open anterior chamber angles (Fig 3). Hematoxylin-eosin staining
on the plastic sections confirmed the open angles after laser
treatment. Our mouse model thus presents one of the main
characteristics, open anterior chamber angle, of human POAG,
and may serve as an option for animal research on open angle
glaucoma. Our data also indicate that SD-OCT is effective to
examine the anterior chamber and the 360 degrees of the angle of
mouse eye. Since OCT scanning can be done on live animals
under anesthesia, it can be used to track the angle changes
throughout the entire period of an experiment.
By definition, glaucoma is a group of diseases that damage the
RGC and optic nerve. Pattern electroretinogram (PERG) is a well-
established method to assess RGC function [46,47]. PhNR, a
component of the full-field ERG, is another method to assess RGC
function in glaucoma patients since 1999 [48,49]. Both PhNR and
PERG are nearly equal in detecting early glaucoma in human
patients [50]. The PhNR component of the full-field ERG can be
recorded in mice and is sensitive to elevation of IOP [51]. In this
mouse model, we demonstrate that PhNR amplitude of eyes with
IOP elevation caused by laser photocoagulation was reduced
dramatically (Fig 4), consistent with the RGC loss and optic nerve
damage (Fig 5). On the other hand, the outer layers of retina were
not damaged by laser treatment (Fig 5A), which is consistent with
the ERG results that a-wave and b-wave of the ERG remained
similar between the laser-treated eyes and contralateral untreated
eyes (Fig 4).
Aging produces a decreased TM cellularity and additional
cellular loss beyond that of normal aging has been found in the
TM of human glaucomatous eyes [14–22]. The ECM of the TM is
thought to be important in regulating IOP in both normal and
glaucomatous eyes. The ECMs of the TM beams, JCT and
Schlemm’s canal inner wall are comprised of fibrillar and non-
fibrillar collagens, elastin containing microfibrils, matricellular and
structural organizing proteins, glycosaminoglycans and proteogly-
cans. The ECM of outflow pathway is relatively dynamic,
undergoing constant turnover and remodeling [4]. F-actin
architecture in the TM cells responds to the local environment
changes [52–54]. With laser photocoagulation, we show that the
TM cell layers were decreased (Fig 8) and the ECM of the TM
and JCT became compacted and disorganized (Fig 8).
SPARC (secreted protein, acidic and rich in cysteine) is a
matricellular protein associated with increased fibrosis and
glaucoma pathogenesis [55]. Studies have shown that SPARC-
null mice have reduced IOP [55] and overexpression of SPARC in
the TM of perfused cadaveric human anterior segments increases
IOP [56,57]. To determine whether laser photocoagulation
induces inflammatory response and fibrotic changes in TM tissue
resulting in IOP elevation, the expression of inflammatory cell
marker CD45 and fibrotic marker SPARC in laser-treated and
control eyes was examined using cryosections and wholemount
tissues. CD45 inflammatory cells increased dramatically in the TM
region 1 week after laser (Fig 7). The expression of SPARC
increased in the TM region beginning 1 week after laser treatment
(Fig 6). This finding is consistent with previous discoveries that
SPARC has a regulatory role in IOP [56]. We speculate that
inflammatory response after laser plays a role in promoting the
fibrotic changes of the ECM and the combined changes of TM
cellularity and ECM after laser photocoagulation are the main
cause for IOP elevation.
The functional morphology of the mouse outflow pathway is
similar to that of humans. The mouse eye resembles the human
eye not only in the presence of a continuous Schlemm’s canal and
comparable TM, but also in the three dimensional elastic fiber
network connected to the inner wall, to ciliary muscle and to
choroidal vessels. All these are very important to control aqueous
outflow (Lutjen-Drecoll E, et al. IOVS 2013; 54: ARVO E-
Abstract 3544). Our mouse model produces the pathological
changes which block the outflow pathway in a similar way to that
found in glaucomatous humans. It induces long-lasting IOP
elevation, outflow structural changes including disorganized ECM
(Fig 8), open anterior chamber angle, loss of RGC axons and
decreased PhNR, mirroring all the characteristics of human
POAG. Using stem cells to reconstruct the TM in glaucomatous
eyes is one of the potential therapy strategies for POAG. We
previously demonstrated that adult stem cells have an ability to
remodel tissue matrix [39]. We also reported that stem cells from
human TM can home to the TM region after being transplanted
into normal mouse anterior chamber [38]. We hypothesize that
once the decreased TM cellularity in glaucomatous eye is
repopulated and the ECM is remodeled after stem cell transplan-
tation, the outflow facility will be restored which would reduce the
increased IOP back to normal. A suitable animal model for cell-
based therapies requires TM cellular damage, outflow pathway
ECM changes with open anterior chamber angle from which
exogenous stem cells can access and target to the TM. We
therefore speculate that this mouse glaucoma model could be
valuable for studies of TM stem cell-based therapies for glaucoma
on reconstructing the outflow pathway both morphologically and
functionally. Work is ongoing to determine the ability of adult
stem cells to home to damaged TM tissue and remodel the tissue
to regulate IOP.
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